The 12 closest competitors and alternatives to Quantumcyte Inc. among biotechnology companies — ranked by similarity to what Quantumcyte Inc. actually does, not by market-cap band.
Subscribe to see Quantumcyte Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
QuantumCyte, Inc. operates in the biotechnology research industry, focusing on specialized cellular and tissue analysis solutions. Founded in 2013, the company is headquartered in Fremont, California.
Quantumcyte Inc. is a biotechnology company headquartered in United States. Its most recent funding round, Series A, raised $1.1M in June 2023. Xcout tracks 4 named people at Quantumcyte Inc., including Fernando Fonseca (Chief Financial Officer).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $1.1M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Quantumcyte Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Deep Cell Industries Inc. provides an AI-integrated platform called REM-I that combines label-free imaging, deep learning, and cell enrichment for single-cell morpholomic analysis. The company serves researchers and organizations in oncology, drug discovery, cell and gene therapy, and related life science fields by enabling high-resolution profiling and sorting of viable cells.
Diagnostics
Techcyte, Inc. is a software and digital pathology company headquartered in Orem, Utah, that provides an artificial intelligence platform for anatomic and clinical pathology workflows.
Similar biotechnology company
ThinkCyte is a biotechnology company founded in 2016 with offices in Tokyo, Japan and Redwood City, California. The company develops innovative technologies such as the VisionSort cell sorting system.
Similar biotechnology company
Cellply is a biology-focused deep tech company based in Bologna, Italy, specializing in biotechnology research. It develops advanced analytical tools and end-to-end single cell potency solutions to study cellular functions.
Similar biotechnology company
Newomics Inc. is a privately-held biotechnology company headquartered in California that develops and commercializes advanced mass spectrometry solutions. The company provides innovative front-end systems and analytical tools for life sciences and research markets.
Life Sciences
Handyem was a Canadian life sciences company based in Quebec City, established in 2011 to develop advanced flow cytometry instruments utilizing optical fiber microfluidic technology. The company, which is now permanently closed, focused on its mission to democratize cytometry.
Similar biotechnology company
Hepta Bio, Inc. focuses on developing liquid biopsy technology for metabolic dysfunction-associated conditions, with headquarters in California.
Life Sciences
QuantaLife, Inc. is a life sciences and biotechnology company based in Pleasanton, California, that develops advanced genetic analysis systems and third-generation PCR technology using Droplet Digital PCR for nucleic acid quantification. The company was acquired as a subsidiary by Bio-Rad Laboratories, Inc. and specializes in tools for the diagnosis and treatment of inherited disorders, cancer, and infectious diseases.
Biotech
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.
Similar biotechnology company
Novilytic develops bioanalytical products and kits, notably the Proteometer platform, which streamlines protein-quality analysis for pharmaceutical laboratories. The company's technology enables rapid assessment of titer, aggregates, and charge variants for monoclonal antibodies, multispecifics, and fusion proteins while eliminating traditional sample preparation and purification steps.
Biotech
Slingshot Biosciences, Inc. develops synthetic biology-based biomimetic cells and cell-like materials that replicate key properties of biological cells. Its products serve life-science researchers, diagnostic developers, and clinical laboratory and instrument manufacturers for applications such as assay development, quality control, and instrument validation.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Quantumcyte Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →